Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

I think the odds for a preclinical drug for a specific indication running the gauntlet and making it to the market is very low. I can't remember what the odds are but I think it's less than 20% and may be the 10% he speaks of. I'm not sure.

However, as new investors look at iPIX they should realize very quickly that this company has several drugs in the pipeline. One of those drugs also has several indications iPIX is testing it out on and that drug has made it to phase 3 in one. And about to possibly make phase 3 in 2 more indications.

The risk here is much much lower than the typical start up biotech - it is no one trick pony.

Kevetrin update would be nice IMO. Maybe we will get cohort 1 data soon. Jmo